Article Information
vol. 13 no. 576
- Received for publication February 19, 2020
- Resubmitted July 23, 2020
- Accepted for publication October 14, 2020
- .
Author Information
- Tino Vollmer1,2,3,
- Stephan Schlickeiser1,2,
- Leila Amini1,2,3,
- Sarah Schulenberg2,
- Desiree J. Wendering1,2,3,
- Viqar Banday4,5,
- Anke Jurisch1,2,3,
- Rebecca Noster2,
- Desiree Kunkel2,
- Nicola R. Brindle2,
- Ioannis Savidis2,
- Levent Akyüz1,2,
- Jochen Hecht6,7,
- Ulrik Stervbo8,
- Toralf Roch2,8,
- Nina Babel2,8,
- Petra Reinke2,3,
- Ola Winqvist9,
- Amir Sherif4,
- Hans-Dieter Volk1,2 and
- Michael Schmueck-Henneresse1,2,3,*
- 1Institute of Medical Immunology, Charité – Universitätsmedizin Berlin, D-13353 Berlin, Germany.
- 2Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité – Universitätsmedizin Berlin, D-13353 Berlin, Germany.
- 3Berlin Center for Advanced Therapies (BeCAT), Charité – Universitätsmedizin Berlin, D-13353 Berlin, Germany.
- 4Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 901 85 Umea, Sweden.
- 5Department of Clinical Microbiology, Immunology, Umea University, 901 85 Umea, Sweden.
- 6Centre for Genomic Regulation, Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
- 7Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain.
- 8Center for Translational Medicine, Medical Clinic I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, D-44623 Herne, Germany.
- 9Department of Clinical Immunology, Karolinska University Hospital, 17 176 Stockholm, Sweden.
- ↵*Corresponding author. Email: michael.schmueck-henneresse{at}charite.de